Skip to Main Content

Paper Details

Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma.
Mol Cancer Ther
19
2022
Author NameAffiliation
Darren EnnisOvarian Cancer Action Research Centre, Imperial College London
Darren EnnisInstitute of Cancer Sciences, University of Glasgow
Peter D AdamsInstitute of Cancer Sciences, University of Glasgow
Peter D AdamsCancer Research UK Beatson Institute
Peter D AdamsSanford Burnham Prebys Medical Discovery Institute
Robert BrownOvarian Cancer Action Research Centre, Imperial College London
Iain A McNeishOvarian Cancer Action Research Centre, Imperial College London
Iain A McNeishInstitute of Cancer Sciences, University of Glasgow
  • 1 - 8

Datasets